Blood DNA methylation levels of the oxytocin promoter predict conversion from mild cognitive impairment to dementia in females within a clinical cohort of cognitive complaints
Philippos Koulousakis, Rick A. Reijnders, Inez H.G.B. Ramakers, Frans R.J. Verhey, Tim Vanmierlo, Daniël van den Hove, Renzo J. M. Riemens
medRxiv · Aug 28, 2024 · PreprintGenetic & Genomic Medicine